FDA Drug Application (020186) for ZIAC by TEVA WOMENS

Back to FDA Applications sponsored by TEVA WOMENS

Application Number020186
Product Number001
FormTABLET;ORAL
Dosage5MG;6.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameZIAC
Active IngredientBISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient BISOPROLOL FUMARATE4
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by TEVA WOMENS